Cell & Bioscience (Jul 2022)

Myometrial oxidative stress drives MED12 mutations in leiomyoma

  • Yinuo Li,
  • Xiuhua Xu,
  • Huma Asif,
  • Yue Feng,
  • Brendan F. Kohrn,
  • Scott R. Kennedy,
  • J. Julie Kim,
  • Jian-Jun Wei

DOI
https://doi.org/10.1186/s13578-022-00852-0
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 17

Abstract

Read online

Highlights High rate of MED12 mutations and leiomyoma burden are clearly associated with myometrial oxidative stress. MED12 mutations are driven by misrepair of 8-OHdG at c.130-c.131 detected by deep sequencing analysis both in vitro and in vivo.

Keywords